Theratechnologies

THTX67

Penny Stock

$1.25arrow_drop_up4.16%$0.05

Penny Stock

THTX67

$1.25

arrow_drop_up4.16%$0.05

Penny Stock

Performance History

Key Stats
Open	$1.31
Prev. Close	$1.37
EPS	-0.14
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$62.31M
PE Ratio	-

	LOW	HIGH
Day Range	1.16	1.31
52 Week Range	0.88	2.58

Ratios

Revenue	-





EPS	-0.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Theratechnologies (THTX)

Theratechnologies Inc. (THTX) is a pharmaceutical company that specializes in the research, development, and commercialization of therapeutic products for the treatment of various medical conditions. The company's primary focus is on the field of HIV/AIDS, with a portfolio of products targeting this disease. With a strong commitment to innovation and a dedication to improving patient outcomes, Theratechnologies has become a leader in the field of HIV/AIDS therapeutics. The company is headquartered in Montreal, Canada, and operates in various markets around the world.

One of the key factors to consider when evaluating a company's stock is its price history. Taking a look at Theratechnologies' stock price history, we can see that it has experienced both ups and downs over the years. The stock has had periods of significant growth, followed by periods of decline. This volatility can be attributed to various factors, such as changes in the market, industry trends, and company-specific events.

In recent news, Theratechnologies announced the launch of a new product that has the potential to significantly improve patient outcomes. The company's latest innovation is expected to address a key unmet medical need in the field of HIV/AIDS. This news has generated a lot of interest among investors and industry experts, as it demonstrates Theratechnologies' ongoing commitment to innovation and its ability to meet the evolving needs of patients.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Paul Lévesque
Headquarters: Montreal
Employees: 144
Exchange: NASDAQ

Keep an eye on Theratechnologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Theratechnologies 's (THTX) price per share?

The current price per share for Theratechnologies (THTX) is $1.25. The stock has seen a price change of $0.05 recently, indicating a 4.17% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Theratechnologies (THTX)?

For Theratechnologies (THTX), the 52-week high is $2.58, which is 106.4% from the current price. The 52-week low is $0.88, the current price is 42.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Theratechnologies (THTX) a growth stock?

Theratechnologies (THTX) has shown an average price growth of 0.41% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Theratechnologies as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Theratechnologies (THTX) stock price performance year to date (YTD)?

As of the latest data, Theratechnologies (THTX) has a year-to-date price change of -26.04%. Over the past month, the stock has experienced a price change of -9.42%. Over the last three months, the change has been -5.3%. Over the past six months, the figure is 2.46%.

help

Is Theratechnologies (THTX) a profitable company?

Theratechnologies (THTX) has a net income of -$23.96M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 75.99% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.93% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 2.13%, providing insight into the company's sales performance and growth. The gross profit is $62.13M. Operating income is noted at -$10.63M. Furthermore, the EBITDA is $8.62M.

help

What is the market capitalization of Theratechnologies (THTX)?

Theratechnologies (THTX) has a market capitalization of $63.05M. The average daily trading volume is 28.58K, indicating the stock's liquidity and investor engagement.

News

CONTRACT MANUFACTURER

9/17/2024

Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025

Theratechnologies annonce un risque d’interruption temporaire de l’approvisionnement d’EGRIFTA SVᴹᴰ au début de 2025

Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2024 et fera une mise à jour de ses activités

CALENDAR OF EVENTS

6/26/2024

Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2024 et fera une mise à jour de ses activités

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

CALENDAR OF EVENTS

6/26/2024

Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update

6/5/2024

Theratechnologies (THTX) Is Attractively Priced Despite Fast-paced Momentum

Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Theratechnologies (THTX)

Keep an eye on Theratechnologies

Frequently Asked Questions

What is Theratechnologies 's (THTX) price per share?

What is the 52-week high and low for Theratechnologies (THTX)?

Is Theratechnologies (THTX) a growth stock?

What is Theratechnologies (THTX) stock price performance year to date (YTD)?

Is Theratechnologies (THTX) a profitable company?

What is the market capitalization of Theratechnologies (THTX)?

News

Sign up for our newsletter

Take Your Investments to a Whole New Level